AFT Pharmaceuticals
AFT.NZ
#8537
Rank
โ‚น13.55 B
Marketcap
โ‚น129.28
Share price
0.00%
Change (1 day)
-19.05%
Change (1 year)

Revenue for AFT Pharmaceuticals (AFT.NZ)

Revenue in 2024: โ‚น10.08 Billion

According to AFT Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น10.08 Billion. In 2024 the company made a revenue of โ‚น10.08 Billion an increase over the revenue in the year 2023 that were of โ‚น8.50 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AFT Pharmaceuticals from 2016 to 2024

Annual revenue

Year Revenue Change
2024โ‚น10.08 B18.51%
2023โ‚น8.50 B7.95%
2022โ‚น7.87 B14.43%
2021โ‚น6.88 B24.62%
2020โ‚น5.52 B9.6%
2019โ‚น5.04 B0.12%
2018โ‚น5.03 B19.33%
2017โ‚น4.22 B9.68%
2016โ‚น3.84 B